Cytolethal distending toxin induces caspase-dependent and -independent cell death in MOLT-4 cells. 2008

Masaru Ohara, and Tomonori Hayashi, and Yoichiro Kusunoki, and Kei Nakachi, and Tamaki Fujiwara, and Hitoshi Komatsuzawa, and Motoyuki Sugai
Department of Bacteriology, Hiroshima University Graduate School of Biomedical Sciences, Hiroshima, Japan. mohara@hiroshima-u.ac.jp

Cytolethal distending toxin (CDT) induces apoptosis using the caspase-dependent classical pathway in the majority of human leukemic T cells (MOLT-4). However, we found the process to cell death is only partially inhibited by pretreatment of the cells with a general caspase inhibitor, z-VAD-fmk. Flow cytometric analysis using annexin V and propidium iodide showed that a 48-h CDT treatment decreased the living cell population by 35% even in the presence of z-VAD-fmk. z-VAD-fmk completely inhibited caspase activity in 24 h CDT-intoxicated cells. Further, CDT with z-VAD-fmk treatment clearly increased the cell population that had a low level of intracellular reactive oxygen. This is a characteristic opposite to that of caspase-dependent apoptosis. Overexpression of bcl2 almost completely inhibited cell death using CDT treatment in the presence of z-VAD-fmk. The data suggest there are at least two different pathways used in CDT-induced cell death: conventional caspase-dependent (early) apoptotic cell death and caspase-independent (late) death. Both occur via the mitochondrial membrane disruption pathway.

UI MeSH Term Description Entries
D011419 Propidium Quaternary ammonium analog of ethidium; an intercalating dye with a specific affinity to certain forms of DNA and, used as diiodide, to separate them in density gradients; also forms fluorescent complexes with cholinesterase which it inhibits. Propidium Diiodide,Propidium Iodide,Diiodide, Propidium,Iodide, Propidium
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D003593 Cytoplasm The part of a cell that contains the CYTOSOL and small structures excluding the CELL NUCLEUS; MITOCHONDRIA; and large VACUOLES. (Glick, Glossary of Biochemistry and Molecular Biology, 1990) Protoplasm,Cytoplasms,Protoplasms
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000590 Amino Acid Chloromethyl Ketones Inhibitors of SERINE ENDOPEPTIDASES and sulfhydryl group-containing enzymes. They act as alkylating agents and are known to interfere in the translation process. Peptide Chloromethyl Ketones,Chloromethyl Ketones, Peptide,Ketones, Peptide Chloromethyl
D001427 Bacterial Toxins Toxic substances formed in or elaborated by bacteria; they are usually proteins with high molecular weight and antigenicity; some are used as antibiotics and some to skin test for the presence of or susceptibility to certain diseases. Bacterial Toxin,Toxins, Bacterial,Toxin, Bacterial
D013194 Staining and Labeling The marking of biological material with a dye or other reagent for the purpose of identifying and quantitating components of tissues, cells or their extracts. Histological Labeling,Staining,Histological Labelings,Labeling and Staining,Labeling, Histological,Labelings, Histological,Stainings
D015853 Cysteine Proteinase Inhibitors Exogenous and endogenous compounds which inhibit CYSTEINE ENDOPEPTIDASES. Acid Cysteine Proteinase Inhibitor,Cysteine Protease Inhibitor,Cysteine Protease Inhibitors,Cysteine Proteinase Antagonist,Cysteine Proteinase Antagonists,Cysteine Proteinase Inhibitor,Cysteine Proteinase Inhibitors, Endogenous,Cysteine Proteinase Inhibitors, Exogenous,alpha-Cysteine Protease Inhibitor,Acid Cysteine Proteinase Inhibitors,alpha-Cysteine Protease Inhibitors,Antagonist, Cysteine Proteinase,Antagonists, Cysteine Proteinase,Inhibitor, Cysteine Protease,Inhibitor, Cysteine Proteinase,Inhibitor, alpha-Cysteine Protease,Inhibitors, Cysteine Protease,Inhibitors, Cysteine Proteinase,Inhibitors, alpha-Cysteine Protease,Protease Inhibitor, Cysteine,Protease Inhibitor, alpha-Cysteine,Protease Inhibitors, Cysteine,Protease Inhibitors, alpha-Cysteine,Proteinase Antagonist, Cysteine,Proteinase Antagonists, Cysteine,Proteinase Inhibitor, Cysteine,Proteinase Inhibitors, Cysteine,alpha Cysteine Protease Inhibitor,alpha Cysteine Protease Inhibitors
D016923 Cell Death The termination of the cell's ability to carry out vital functions such as metabolism, growth, reproduction, responsiveness, and adaptability. Death, Cell

Related Publications

Masaru Ohara, and Tomonori Hayashi, and Yoichiro Kusunoki, and Kei Nakachi, and Tamaki Fujiwara, and Hitoshi Komatsuzawa, and Motoyuki Sugai
February 2010, Infection and immunity,
Masaru Ohara, and Tomonori Hayashi, and Yoichiro Kusunoki, and Kei Nakachi, and Tamaki Fujiwara, and Hitoshi Komatsuzawa, and Motoyuki Sugai
January 2017, PloS one,
Masaru Ohara, and Tomonori Hayashi, and Yoichiro Kusunoki, and Kei Nakachi, and Tamaki Fujiwara, and Hitoshi Komatsuzawa, and Motoyuki Sugai
January 2022, Frontiers in cellular and infection microbiology,
Masaru Ohara, and Tomonori Hayashi, and Yoichiro Kusunoki, and Kei Nakachi, and Tamaki Fujiwara, and Hitoshi Komatsuzawa, and Motoyuki Sugai
December 1999, Infection and immunity,
Masaru Ohara, and Tomonori Hayashi, and Yoichiro Kusunoki, and Kei Nakachi, and Tamaki Fujiwara, and Hitoshi Komatsuzawa, and Motoyuki Sugai
August 2009, Infection and immunity,
Masaru Ohara, and Tomonori Hayashi, and Yoichiro Kusunoki, and Kei Nakachi, and Tamaki Fujiwara, and Hitoshi Komatsuzawa, and Motoyuki Sugai
May 2004, Journal of immunology (Baltimore, Md. : 1950),
Masaru Ohara, and Tomonori Hayashi, and Yoichiro Kusunoki, and Kei Nakachi, and Tamaki Fujiwara, and Hitoshi Komatsuzawa, and Motoyuki Sugai
July 1999, Trends in microbiology,
Masaru Ohara, and Tomonori Hayashi, and Yoichiro Kusunoki, and Kei Nakachi, and Tamaki Fujiwara, and Hitoshi Komatsuzawa, and Motoyuki Sugai
January 2006, Microbiological research,
Masaru Ohara, and Tomonori Hayashi, and Yoichiro Kusunoki, and Kei Nakachi, and Tamaki Fujiwara, and Hitoshi Komatsuzawa, and Motoyuki Sugai
April 2010, Helicobacter,
Masaru Ohara, and Tomonori Hayashi, and Yoichiro Kusunoki, and Kei Nakachi, and Tamaki Fujiwara, and Hitoshi Komatsuzawa, and Motoyuki Sugai
February 2024, Pathogens (Basel, Switzerland),
Copied contents to your clipboard!